TrialBreast (Edinburgh, Scotland)2024

Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial.

Karolina Larsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.